FASLG and autoimmune disease: Although effective in suppression of immune activity, thus causing immune privilege, short-term therapeutic activity of proteins encoding FasL is not always sufficient in the induction of transplant tolerance and abrogation of autoimmune disorders, which are frequently broken by incidental infections and relapse of autoimmunity [18].